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Background: An important prelude to developing strategies to control infectious diseases is a detailed
epidemiological evidence platform to target cost-effective interventions and define resource needs.
Methods: A review of published and un-published reports of malaria vector control and parasite prevention in
Uganda was conducted for the period 1900–2013. The objective was to provide a perspective as to how
epidemiological intelligence was used to design malaria control before and during the global malaria eradication
programme (GMEP) and to contrast this with the evidence generated in support of the Roll Back Malaria (RBM) initiative
from 1998 to date.
Results: During the GMEP era, comprehensive investigations were undertaken on the effectiveness of vector and
parasite control such as indoor residual house-spraying (IRS) and mass drug administration (MDA) at different sites in
Uganda. Nationwide malariometric surveys were undertaken between 1964 and 1967 to provide a profile of risk,
epidemiology and seasonality leading to an evidence-based national cartography of risk to characterize the diversity of
malaria transmission in Uganda. At the launch of the RBM initiative in the late 1990s, an equivalent level of evidence
was lacking. There was no contemporary national evidence-base for the likely impact of insecticide-treated nets (ITN),
no new malariometric data, no new national cartography of malaria risk or any evidence of tailored intervention
delivery based on variations in the ecology of malaria risk in Uganda.
Discussion: Despite millions of dollars of overseas development assistance over the last ten years in ITN, and more
recently the resurrection of the use of IRS, the epidemiological impact of vector control remains uncertain due to an
absence of nationwide basic parasite and vector-based field studies.
Conclusion: Readily available epidemiological data should become the future business model to maximize malaria
funding from 2015. Over the next five to ten years, accountability, impact analysis, financial business cases supported
by a culture of data use should become the new paradigm by which malaria programmes, governments and their
development partners operate.
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Over the last decade Uganda has received over US$600
million in overseas development assistance from multi-
lateral and bilateral development partners to control
malaria. The interest in malaria as an impediment to
Uganda’s development was first highlighted during the
colonial era [1,2]. Later, in 1950, the first malaria confer-
ence in Equatorial Africa, convened by the World Health
Organization (WHO), was held in Kampala, Uganda
[3-5]. This landmark conference was used to present
and assess all the available information on the epidemio-
logical aspects of malaria and attempted to coordinate
the various methods of research and control of the dis-
ease. One major recommendation of the conference was
that the benefits that malaria control might bring to the
indigenous populations should be evaluated [3-5]. The
role of research as a means to address the technical
problems of malaria control in tropical Africa was inte-
gral to the Global Malaria Eradication Programme
(GMEP) effort. The 1950 Kampala conference catalyzed
many studies and epidemiological investigations in
Africa, including a number of important field trials
aimed at the ‘eradication’ (appropriate term should have
been elimination) of malaria.
However, after 1969, efforts to control the disease were
disrupted when the WHO put on hold the goal of mal-
aria eradication [6]. From the early 1970s to the late
1980s, political and economic turmoil curtailed any rea-
sonable malaria control in Uganda. Renewed interests in
malaria control in the country were started in the 1990s,
after the endorsement of the global malaria strategy in
1993 [7] and were initially supported by the World Bank
[8]. Coincidentally, during this period, treatments for
malaria started failing and the country found itself with
repeated malaria epidemics and an escalating disease
burden [9,10]. In 1998, the Roll Back Malaria (RBM)
initiative was launched [11], followed, in 2002, by op-
portunities to access new funding through the Global
Fund [12].
Methods and literature abstraction
Published and un-published reports about malaria vector
control and parasite prevention in Uganda for the period
1900 to 2013 were reviewed. The objectives were to
provide a historical overview and evolution of malaria
vector control and parasite prevention from the pre-
eradication period to the era of the Global Malaria
Eradication Programme (GMEP) to the present Roll
Back Malaria-RBM control period. This review was mo-
tivated by a need to: a) capture a historical perspective
of malaria vector control and parasite prevention to
draw lessons for today’s control/elimination ambitions;
and b) maintain an institutional memory of the past ef-
forts of malaria vector control and parasite prevention inUganda - who was involved, what was done, what
worked and more importantly what did not work.
Online electronic literature databases were used as
one means for identifying peer-reviewed, published pa-
pers. Due to its wide coverage of the biomedical litera-
ture, PubMed was used as the basis for all the initial
online searches of published sources. In addition, the
World Health Organization Library Database and the
African Journals Online (AJOL) was used to search for
relevant literature. In all digital electronic database
searches for published work the free text keywords “mal-
aria” and “Uganda” were used. Specialised Medical Sub-
ject Headings (MeSH) terms in digital archive searches
were avoided to ensure as wide as possible search inclu-
sion. Further, national malaria control programme docu-
ments at the ministry of health headquarters in Kampala,
Uganda were reviewed. Finally, in 2013, in partnership
with the national malaria control programme (NMCP); all
available epidemiological data on malaria infection preva-
lence were assembled to map malaria risk in Uganda at a
resolution of 112 districts to support the future analysis of
change since 2000. The statistical models used to derive
the Uganda malaria risk map are already published
[13]. The review further describes how research evi-
dence and epidemiological intelligence was used to
shape policy and design malaria control in Uganda
during the GMEP period and compares and contrasts
this with the evidence generated over 50 years later in
support of the RBM initiative.
Review findings
Defining the malaria burden in Uganda 1929–1950
The precise burden of malaria and its distribution coun-
trywide was unclear to those responsible for health sta-
tistics between the two World Wars [1]. As stated in the
1927 Annual Report of the Medical Department “The
very low number of deaths recorded under clinical mal-
aria, i.e. malaria in which the diagnosis was not con-
firmed by the microscope, is explained by the fact that
most of these cases were mild and attended to as out-
patients, when the facilities for microscopic diagnosis
were not always possible” [2].
After the Second World War, malaria epidemics were
noted in the township areas, despite being ‘protected’ by
permanent drainage schemes and routine oiling [2]. At
Kigezi (presently composed of four small districts: Kabale,
Rukungiri, Kanungu, and Kisoro), a highland area in
south-western Uganda, reports emerged of malaria cases
from areas previously considered free of the disease [2].
However, by 1950, a review of statistics suggested that
malaria mortality among hospital admissions might have
declined over the previous 20 years among Europeans and
Asians, and it was an unusual event to become infected
with malaria in some of the major towns. Although
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control, the 1950 Annual Report noted as follows “the
available evidence suggests that no appreciable change
has taken place in its incidence among general African
population” [2]. The precise malaria burden among the
entire Ugandan population continued to remain an
elusive statistic even up to 1950, not least because 80%
of the diagnoses of malaria at hospitals were unsup-
ported by microscopic examination [2].Malaria eradication experimental pilot projects
It was not until the late 1950s, after the WHO Kampala
Conference, that a concerted effort was mounted to
understand the complex epidemiology of malaria in rela-
tion to its control. ‘Eradication’ experimental pilot projects
were supported by rigorous evaluation with pre- versus
post-intervention trials of vector and parasite-based con-
trol at four locations (Kigezi in south western, Masaka in
Central, Lugazi and Kakira in Eastern Uganda).Northern Kigezi (1959–1964)
Between 1957 and 1958, comprehensive human and
vector-based studies were undertaken to characterize the
epidemiology of malaria in a government resettlement
scheme of approximately 50,000 people in northern
Kigezi district [14]. In 1959, the experimental intervention
studies focussed on three annual rounds of indoor residual
spraying (IRS) with dichloro-diphenyl-trichloroethane
(DDT), 2 g per sq m of sprayed surface, and three rounds
of mass drug administration (MDA) with single doses of
chloroquine (200 mg base) and pyrimethamine (16.5 mg
base) (CQ/P). By 1959, the project had been extended to
the entire Kigezi district [14]. An important component of
these interventions was monitoring and evaluation (M &
E), including: community and school surveys of infection
prevalence by species and spleen rates among children
aged two to nine years; monthly infant parasite prevalence
surveys at dispensaries and health posts before and after
spraying; monthly fever surveys during visits to the
health facilities; sampling adult indoor-resting mosqui-
toes, outdoor-resting traps for outdoor catches; larval
searches as part of reconnaissance surveys; use of ex-
perimental huts; establishment of laboratory colonies;
and, breeding of mosquitoes under uniform conditions
for bioassay tests and experimental work. In addition, a
series of bioassay tests were carried out in the experi-
mental huts to ascertain the decline of the toxic effect
of DDT deposits, as well as susceptibility tests to deter-
mine the susceptibility of adult mosquitoes and larvae
to insecticides [14]. Further, the field teams collected ro-
bust operational coverage data of every single human
dwelling and animal shelter and the composition of
spraying squads [14].Anopheles gambiae s.l. was the main vector through-
out the Kigezi area, with Anopheles funestus playing a
secondary role in malaria transmission in a few localities
[14,15]. During the first year of the operations, there was
an almost complete disappearance of malaria: parasite
prevalence among children aged two to nine years de-
clined from 16.6 to 0.3%; the number of An. gambiae
and An. funestus found resting in houses, which was, at
baseline, between 26.5 and 43.5 per house, respectively,
was reduced to practically nil after DDT spraying. How-
ever, the outdoor-resting vector populations remained
unchanged during the first six months, but were sub-
stantially reduced thereafter and only An. funestus was
occasionally found, suggesting a six-month lag between
reductions of indoor- and outdoor-resting vector popu-
lations. The average number of monthly An. gambiae
entering treated huts and caught in window traps de-
clined by two-thirds after nine months. Surveys carried
out in neighbouring districts showed practically no re-
duction in malaria rates [14,16]. By 1963, the malaria
eradication experiment in North Kigezi was deemed a
success, having eliminated malaria (reduction in parasite
rate by a factor of 50 to 1) from almost the entire district
[14]. However, imported malaria led to localized out-
breaks in the later stages of the scheme because malaria
was never completely interrupted in the areas adjoining
the protected areas of North Kigezi [14].
Kigezi highlands (1960–1964)
Following the success of the campaign in North Kigezi,
and an attempt to prevent the rate of new infections be-
ing brought into the protected areas, it was decided to
extend the eradication operations to the whole of Kigezi
district. The malaria ‘eradication’ measures used in the
Lake Bunyonyi area were similar to those used in the
North Kigezi programme [14,17] with the exception that
there were two rounds instead of three of MDA with
CQ/P. The results of the Lake Bunyonyi campaign were
equally impressive: not a single An. funestus was observed
in six surveys conducted after DDT spraying, from February
1961 to May 1962. In spite of the complete elimination of
An. funestus from the area, other less dominant anophe-
lines were implicated in transmission, including: Anoph-
eles coustani, Anopheles listeri, Anopheles marshalli, and
Anopheles kingi [17]. Parasite prevalence in children aged
two to nine years declined from 21% in 1959 to 0.1% in
1960/1961. De Zulueta and colleagues concluded as fol-
lows: “the results so far obtained in Kigezi indicate the
possibility of malaria “eradication” in the area within a
short time. Preliminary surveys in other parts of Western
and Central Uganda indicate that no more malaria is to
be found there than in Kigezi, thus showing that the
“eradication” of malaria in Central and Western Uganda
is feasible” [17].
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O-dimethyl phosphorodithioate, in Masaka district
(1963–1964)
Between 1963 and 1964, with the assistance of the
WHO, a large-scale field trial of malathion was carried
out in Masaka district [18]. The area of intervention cov-
ered 500 sq km and a population of 26,000 inhabitants.
All houses and animal shelters were sprayed with mala-
thion approximately every four months. Epidemiological
evaluations were organized from November 1964 across
a central area comprising 40% of the sprayed areas using
parasitological and entomological methods developed
during the Kigezi project. The average combined dens-
ities of An. funestus and An. gambiae, in the sprayed
area, declined from 66 per shelter per day in the pre-
trial period 1960–1961 to 0.0011 at the end of 1964. No
significant changes were noted in the non-sprayed areas.
However, the persistence of malaria cases and the obser-
vation of some infections in infants born after the com-
mencement of spraying were reported as not consistent
with the entomological observations. Further epidemio-
logical investigations revealed that there were constant
movements of the population in and out of the small
intervention area and consequently a high rate of au-
tochthonous cases due to imported infections [18].
Chloroquine-medicated salt for malaria suppression Lugazi
and Kakira (1964–1965)
A mixture of CQ with common salt had been proposed
as an alternative method for MDA in situations where
insecticide spraying was not effective [19]. A trial began
in Uganda between 1964 and 1965, involving the free
distribution of CQ-medicated salt to workers and their
dependants at two sugar estates, Lugazi and Kakira in
Eastern Uganda [20]. Prior to the launch of the trial, it
had been shown that IRS using DDT was unsuccessful
in removing malaria infection in the highly mobile im-
migrant labour force at these estates that recruited
people from all over Uganda and Rwanda and employed
circa 10,000 people on each estate. Weekly administra-
tion of CQ tablets had been tried but abandoned due to
widespread objections to the bitter taste. The effects of
the MDA programme were assessed using mass blood
examinations and morbidity data comparing recipient
populations with similar populations on the estate not
receiving the medicated salt. The results of this pilot ex-
periment were inconclusive. There were no differences
in infection or morbidity among children during 1964;
larger differences were observed by 1965 notably among
adults, a 30% decline in morbid events, but not among
infants. There were problems with irregular distribution
of CQ-medicated salt and some households bought al-
ternative salt supplies from shops to avoid the bitter
taste. Overall, it was concluded that with the satisfactorydistribution of CQ-medicated salt, significant reductions
in the crude parasite rates and morbidity could be
achieved. Failure to achieve complete suppression be-
cause of operational shortcomings, individual non-
cooperation and inadequate uptake of the medicated salt
meant that the wider adoption of this strategy was never
pursued [20].
Developing an epidemiological profile of malaria risk
(1965–1967)
Building an epidemiological profile formed a major ef-
fort of the mid-1960s ‘pre-eradication’ effort, resulting in
intensive and extensive investigations in some areas and
wider mapping of risk across the country. The largest
surveys were undertaken in Kigezi (presently composed
of four small districts), Masaka district (presently com-
posed of eight small districts), Busoga district currently
composed of ten smaller districts, and Karamoja district
currently composed of seven smaller districts [14-17,21-23].
For reasons not entirely clear, the central region was ex-
cluded. During these surveys, the field teams described
the topography, the climate including temperature, hu-
midity, winds, peak rainfall, and the main agricultural
pre-occupation of surveyed localities. Field operations
were initiated in February 1964 and continued until the
end of 1967.
Malariometric, monthly infant and fever surveys and
entomological surveys were carried out at regular intervals
at ten selected localities in each district (except Karamoja
where 15 sites were selected). School surveys were also
carried out at all the sites at approximately three-monthly
intervals, while general mass population surveys were
conducted at eight of the ten localities at six-monthly in-
tervals. Blood films were taken by medical assistants in
charge of the medical units and collected every fortnight
by project staff for examination at a central laboratory at
the district headquarters. Eight indicator localities were se-
lected in each district for monthly entomological surveys;
including: daytime spray catches in eight fixed houses of
different types of structures; all human and animal landing
night catches indoors and outdoors for two consecutive
nights (four localities); window trap observations (four lo-
calities); identification of the blood digestion stages and
salivary gland dissections; identification of blood meals
from samples collected in different types of structures
[21-24]. These were some of the most significant national
examinations of the epidemiology of malaria risk in Africa
at the time.
The national patterns of malaria endemicity were re-
corded following the classifications formulated at the
1950 Kampala malaria conference [3,4], initially based
on spleen rates and later revised to parasite rates in chil-
dren aged two to nine years old [25]. The eradication
headquarters at Jinja town in Eastern Uganda housed all
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nately destroyed.
The assembled data provided an information platform
necessary to produce cartographies of risk, which was
used for many years after the surveys were completed
(Figure 1A) [24]. MacRae’s chapter on malaria in the
book Atlas of Disease in Uganda, edited by Hall and
Langlands, first published in 1968 and revised in 1975 is
an important insight for today’s malaria control/elimin-
ation epidemiologists [24,26]. Over 50 years ago, the car-
tography of disease distributions was regarded as a
necessary public health tool. The book drew attention to
the diversity of national risks, illustrated the complexity
of the geographical patterns of diseases and noted that
the precise limits of the distribution of many diseases
were set by environmental factors [24,26]. The Atlas
highlighted the interaction between altitude, open water
and swamps, temperature, rainfall, vegetation, human
geography, migration/immigrants, urbanization, food
crops, economic factors, and population density as
drivers of disease distribution. This geography of disease
led to important observations, including the correspond-
ence between Epstein Bar virus, malaria and Burkitt’s
lymphoma [27-30] and the drivers of childhood diseases
and malnutrition [31]. Few attempts have since been
made to describe the sub-national patterns of disease
through multidisciplinary studies conducted in collabor-
ation with epidemiologists and geographers.
The intention of the pre-eradication national surveys
and disease atlases was that the assembled and mappedFigure 1 Malaria risk maps developed in A) 1960s, B) 1990s and C) 2013. A
1965–1967 [24]. B) Malaria risk map used in national malaria strategies and ot
[24], complimented by data collected in the early 2000 [44,45]. C) Population
a Bayesian hierarchical space-time model was implemented through Sto
Laplace Approximations for inference [13]. The covariates were used together
suitability index, precipitation, enhanced vegetation index and urbanization. C
continuous maps of PfPR2–10 and matching population density grids projecte
positive and the populations at risk by district at each 1 × 1 km PfPR2–10 grid ldata would serve as a baseline for future planning and
monitoring. Following independence in 1962, Uganda
entered a period of sustained political and social turmoil
that lasted for decades. It is therefore not surprising that
such national surveillance was not mounted at national
or sentinel level for another 50 years.
Re-establishing epidemiological enquiry 1995–2010
Between 1990 and 1996, a few isolated studies of the
epidemiology of malaria were supported by the German
development cooperation in two western Uganda dis-
tricts (Kabarole and Bundibugyo). These studies were
important in providing contemporary data on the micro-
epidemiology of malaria in Uganda, assessing the know-
ledge, attitudes and practices towards malaria, its treat-
ment and prevention as well as providing crude
estimates of malaria specific mortality rates in different
endemicity zones in these two districts [32]. In 1995, the
Uganda Ministry of Health established a malaria control
unit (MCU) [33]. However, the precise burden of the
disease remained elusive during this period.
In 1998, a member of Uganda’s legislature (Parliament)
requested that the Minister for Health provide the mor-
tality estimates for malaria in Uganda disaggregated by
age and sex for each of the then 39 Ugandan districts.
When the Minister for Health asked the MCU team to
provide the information to help him respond to Parlia-
ment’s request, the first response to the Minister was
that it was not possible to provide such estimates with
the available data. The health minister noted as follows:) Malaria endemicity regions obtained from surveys between
her MoH documents from 2005. Redrawn in colour from data from1967
adjusted mean PfPR2–10 (PAPfPR2–10) in 2010 [77]. To compute PAPfPR2–10
chastic Partial Differential Equations using Integrated Nested
with the parasite rate data to predict malaria risk were temperature
ontinuous maps of PfPR2–10 maps were then predicted at 1 × 1 km. The
d for 2010 were then used to compute the number persons likely to be
ocation. These were then used to compute PAPfPR2–10.
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cause of morbidity and mortality in Uganda, yet there is
no evidence to support that claim” (Kadama Patrick,
persl comm.). The then MCU team, like their counter-
parts in the first half of the Century, continued to strug-
gle to articulate a reliable estimate of the disease burden
nationwide based on routinely available health statistics,
and therefore developed a ‘modelled estimate’ of 70,000
malaria deaths each year (95% confidence interval:
50,000-100,000) [33]. The Minister for Health while
reporting back to the legislature elected to use the upper
limit of 100,000 deaths annually, which was headline
news in one of the national newspapers the following
day: “Malaria kills 100,000 Ugandans every year” [34].
This estimate has been quoted as the country’s malaria
mortality burden up to this day.
This early political plea for better data did, however,
focus the attention of the national malaria control
programme (NMCP) on assembling the evidence and
marked the beginning of the re-establishment of the
central malaria database and annual district morbidity
data summaries (later reviewed in [35,36]). The need for
better data was most urgent for the detection of malaria
epidemics in the highland areas of Uganda, where a lack
of an efficient surveillance system meant that outbreaks
were detected late, had a poor response or were missed
entirely. The first epidemic waves began in July 1994 in
the Kabale and Kisizi regions. In July 1994, 1,684 pa-
tients were admitted to the hospital of Kisizi with a con-
firmed diagnosis of malaria, compared to 200 in July
1993, and 225 in 1995 [37]. Later, the El Niño Southern
Oscillation (ENSO) unstable climate conditions in the
Pacific during 1997–1998 led to exceptional rainfall pat-
terns across East Africa [38] resulting in several dramatic
malaria epidemics. At Kabale, the ENSO effect resulted
in a malaria epidemic that lasted from February to April
1998 [9,10]. Between 1990 and 2000 regular malaria epi-
demics occurred in Kisoro, Rukungiri and Kabale dis-
tricts in the south-western part of the country [35].
The quality, completeness and timeliness of malaria-
related data from the health management information
system (HMIS) slowly increased and improved over the
period 2005–2010. In addition, the NMCP developed a
database of all available information and survey results
including those from the commercial sector. In 2008,
the MCU developed the first ever M&E plan [39] and
the first Malaria Indicator Survey (MIS) was conducted
in 2009 [40]. However, data on inpatient malaria admis-
sions and deaths, although systematically collected in
the HMIS have rarely been analysed. This was partially
addressed through the establishment of five to six senti-
nel hospitals with reasonably reliable data on paediatric
admissions since 2000, and used in a more informed
way to examine disease trends [41].The Uganda Malaria Surveillance Programme (UMSP)
The first attempt in over 50 years to resurrect the notion
of sentinel surveillance was launched in 1997 with the
establishment of the East African Network for Monitor-
ing Anti-malarial Treatment [42,43]. However, the focus
of this surveillance was not on detailed epidemiological
profiling but solely on the patterns of anti-malarial drug
efficacy among clinical patients at eight sentinel sites of
varying malaria transmission intensity [42,43]. In the
early 2000s, more basic transmission data (parasite
prevalence and annual entomological inoculation rates
(AEIRs) were established at these sentinel sites [44,45].
These spatially and temporally limited data were used to
adapt the risk map developed in the 1960s (Figure 1A)
to form an expert-opinion map of risk in 2000 (Figure 1B)
and used in subsequent national strategic plans [46,47],
applications for donor support [48-50] and national
programme reviews [51] up to 2012.
In 2001, the Uganda Malaria Surveillance Programme
(UMSP) was founded, initially as collaboration between
researchers at the Makerere University College of Health
Sciences, the Makerere University School of Public
Health, the Ministry of Health and the University of
California San Francisco. The first focus of UMSP for
the period 2001–2006 was drug resistance surveillance;
however the scope of the research, surveillance and the
collaborators has expanded. In 2006–07, the UMSP ac-
tivities were expanded to include health facility surveil-
lance of malaria, starting with outpatient surveillance in
2006–07 and later adding inpatient surveillance in 2010.
Recently, the UMSP sentinel sites have been expanded
from the original six sites to twenty six malaria reference
centres. In 2008, the Infectious Disease Research Collab-
oration in Uganda (IDRC) was created from the UMSP
[52] and in 2010 the Program for Resistance, Immun-
ology, Surveillance and Modelling (PRISM) of malaria
was set up. The PRISM project builds on the platform of
surveillance established by UMSP. The PRISM projects
include: 1) surveillance; 2) parasite and insecticide resist-
ance; and, 3) immunology. The surveillance project in-
cludes comprehensive surveillance at three sites (Tororo,
Jinja and Kanungu), which includes cohort studies,
cross-sectional community and school surveys, health
centre surveillance and entomology surveys. The overall
strategy is to apply a comprehensive and iterative ap-
proach to malaria surveillance so as to generate an
evidence-base to help maximize the impact of control
interventions across a wide range of epidemiological
settings [53-57].
Generating evidence to evaluate the impact of vector
control 2000–2010
The initial focus for vector control, at the launch of
RBM in Uganda, was on the distribution of insecticide-
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but had failed to achieve any substantial coverage by
2010 [40,58-61]. It is notable that despite ITNs being a
substantial component of all of Uganda’s national mal-
aria strategic plans from 2000–2015 [46,47], there were
limited nationwide attempts to establish any effective
M&E systems to assess the impact of ITN on transmis-
sion or disease outcomes at any site in Uganda, except
for the first MIS conducted in 2009 [40].
Urban malaria control, initially a key strategic interven-
tion in the colonial period, received a renewed interest
during the early 2000s. A community-based environmen-
tal management programme for malaria control was
started in 2002 within two Ugandan cities (Kampala and
Jinja) [62]. A detailed assessment of vector breeding sites
was undertaken at two sites in Kampala (Kitebi and
Kikulu) and two sites in Jinja (Police Barracks and Loco
Estate). In Kampala, the interventions included filling
puddles, introducing larvivorous fish and improving
drainage. In Jinja, the plans focused on building and
repairing drainage channels and soak-pits. Larvicides were
not used. Collections of adult mosquitoes from sentinel
houses suggested that there was a reduction in malaria
transmission, as indicated by a drop in the number of
adult mosquitoes collected. The project also set up a sys-
tem of measuring malaria prevalence in the target areas
and noted a reduction in malaria prevalence of 11% in the
Police Barracks and 36% in Kitebi, providing evidence of
the potential benefits of environmental management for
reducing malaria transmission in these urban settings
[62]. However, urban malaria control has not featured
prominently in any subsequent national malaria strategic
plans and Global Fund applications [46,47,63,64].
Since the studies at Kigezi during the 1960s, IRS had
not been widely utilized in Uganda, with some excep-
tions of the use of lambda cyhalothrin (ICON™ 10% WP)
during the epidemics in the late 1990s and early 2000s
[9,10]. In 2006, the US government’s President’s Malaria
Initiative (PMI) funded activities that focussed on IRS
pilot projects in the south-western highland district of
Kabale. Under a cooperative agreement, Research Tri-
angle Institute (RTI) was contracted by PMI to under-
take environmental and entomological surveys, procure
insecticides and equipment, coordinate community edu-
cation, and implement IRS activities across the whole
district. IRS with lambda-cyhalothrin was carried out
between June and August 2006 and post-IRS surveys
were conducted in September 2006. The only data
provided on the impact of this pilot project included
a description of adverse events and the pre- versus
post-malaria hospital admission rates at Kabale dis-
trict hospital [65]. The following year, 45,000 house-
holds were sprayed in neighbouring Kanungu district
in south-western Uganda.The amount of detailed epidemiological enquiry on
the added value of IRS to ITN remains very limited. Pre-
versus post-spray, health facility-based, slide positivity
rates were conducted at one health centre [66], rates of
infection and anaemia were measured in two spray dis-
tricts compared to a single unsprayed control district
[67] and routine health facility data between March
2007 and October 2011 were analysed for one northern
Uganda district [68]. At the time of writing this manu-
script, IRS was being implemented in ten northern
Uganda districts with the support of PMI. A review of
the IRS programme was conducted in 2014 and ob-
served that there was some evidence of a decline in mal-
aria test positivity rates at health facilities in the districts
where IRS was implemented compared to neighbouring
districts where spraying was not done. A before and
after intervention analysis showed that malaria test posi-
tivity rates dropped from 45 to 25% in the IRS districts
and there was no corresponding drop in the non-IRS
districts [69]. There are some interpretation issues with
test positivity rates due to changing coverage but more
importantly despite over six years of IRS, there are no
rigorous data on the impact on vector populations, bit-
ing rates or infection risks among the infant and wider
communities in these areas, in marked contrast to the
‘pilot’ investigations of IRS during the 1960s. The mal-
aria programme’s mid-term review in 2014 admits “there
are inadequate data to support IRS planning and
decision-making at all levels” [69].
Another example of the inadequacy of epidemiological
intelligence to guide strategic decisions is provided by
the programme initiated by the non-governmental
organization (NGO) Pilgrim Africa [70] using IRS
(lambda-cyalothrin) combined with mass screening and
treatment (MSAT) in two districts, Katakwi and Kumi in
Eastern Uganda. MSAT was conducted using rapid diag-
nostic tests (RDTs) and treatment initially with a dona-
tion of artemisinin-napthaquone (Arco®), a drug not on
the WHO recommended list and thus later replaced
with dihydroartemisinin–piperaquine (DUOCOTEXIN®).
For six to eight months, the malaria cases recorded in
the routine HMIS in Katakwi district are reported to
have dropped by 92% in children under five years old to
4.9% of all outpatient attendances [71]. On the basis of
this alone, a draft proposal called the Accelerated National
Scale-Up of Malaria Control in Uganda (2012 – 2016) to
sustain this pilot project was presented to the Ministry of
Health with a cost projection of US$2.09 billion [71], des-
pite absence of robust epidemiological data on the short-
and long-term impact of such a project.
National population based surveys
As part of the RBMM&E initiative, national household sur-
veys were resurrected as a means to monitor country-level
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ded in the Demographic and Health Surveys (DHS) as a
malaria module and were largely focussed on intervention
coverage measures. In 2005, it was agreed to include mal-
aria infection prevalence into the survey protocols. The
first national parasite prevalence survey since 1967 was
undertaken as part of the Ugandan DHS in 2006 [58] and
subsequently repeated in 2011–12 [73]. In addition, the
first MIS was conducted in 2009 [40] and another was
planned before the end of 2014. Unlike previous national
investigations of the epidemiology of malaria transmission,
these national household surveys focussed only on chil-
dren below the age of five years and sampled small num-
bers of children per village cluster. In contrast, the surveys
undertaken in 1964–1967 examined over 120,000 people
surveying all age groups in ten to 15 locations per region
[13-16,20-23].
In addition to the national household survey data,
there have been multiple school-based surveys under-
taken in different parts of the country since 2001 [74-76]
and other community-based, district-wide surveys under-
taken by NGO partners and research groups. However,
these data had not been systematically assembled nation-
ally and used to define a more elaborate description of
malaria transmission sub-nationally. Despite the availabil-
ity of new data, the Malaria Programme Review conducted
by WHO and national partners in 2010, states that “The
programme has not adopted a system for routine and peri-
odic monitoring of malaria risk in the country” and that
one key issue was “The lack of risk mapping (including
using routine data) makes it difficult to identify popula-
tions at highest risk and targeting of interventions to these
populations” [51].
In 2013, in partnership with the NMCP, all available
epidemiological data were assembled to re-map malaria
risk in Uganda at a resolution of 112 districts to support
the future analysis of change since 2000 and improve the
understanding of previous intervention impact and fu-
ture intervention targeting (Figure C [77]. This work
demonstrated some changes in parasite prevalence in
some districts between 2000 and 2010, but more import-
antly highlighted the intractability of transmission inten-
sity despite current levels of intervention coverage. How
this new epidemiological intelligence will be used for fu-
ture resource planning remains to be seen. However, it
is reassuring to note that the new malaria risk map has
already been used in the formulation of the Uganda
malaria reduction strategic plan, 2014–2020 [63] and in
the funding request to the Global Fund under the new
funding model (NFM) [64].
Discussion
During the GMEP era, from the mid-1950s to the late
1960s, the use of survey data, malaria risk maps andepidemiological intelligence was a routine feature of
malaria control planning in Uganda. Reconnaissance and
detailed research formed the basis of decision- making.
The need to assess the malaria situation and investigate
the epidemiological conditions prevailing nationwide
was critical for malaria programme planning. Extensive
malariometric surveys were undertaken to provide a
profile of risk, epidemiology and seasonality so as to
guide the design of national malaria control/elimination.
Impressively, such surveys were coordinated by the mal-
aria eradication centre and technically supported by epi-
demiologists in the WHO country office. While this old
model of doing business may be challenging in the
present RBM era, because of limitations in the staffing
composition and skills mix at the NMCP and the WHO
country offices, there has been two decades of growth in
research trained staff at universities and national insti-
tutes that can support the malaria programme.
The art and skills necessary to design malaria control
based on an understanding of the spatial epidemiology
were lost post-1969 and recent attempts to build a de-
tailed understanding of risk, disease outcome and inter-
vention impact have been less rigorous compared to the
work carried out by the malariologists of the 1950s and
1960s. The current designs of MIS or DHS, although
useful in providing valuable information on intervention
coverage, are inadequately designed to provide reliable
spatial data on species-specific and age-specific infection
prevalence and do not include an entomological
component.
During the RBM era the detailed evaluation of vector
control impact has been absent in Uganda, despite more
recent investment in sentinel surveillance. The added
value of IRS combined with ITN remains unclear in dif-
ferent transmission settings or when universal access to
LLINs has been achieved [78-80]; the impact of ITNs on
transmission and disease rates at current levels of cover-
age and transmission intensity remain unknown, the role
of MDA, while investigated in detail during the 1950s
has been poorly defined during recent interventions.
There is presently a renewed interest among develop-
ment partners and malaria researchers in the role of
MDA in areas of intense transmission. Any future pilot
experiments of vector control and parasite prevention in
Uganda should be accompanied by robust epidemio-
logical, entomological and community acceptability
evidence, at least to the level of detail provided in the
1950s and 1960s. Moreover, pilot studies should also
assess the long term rather than short-term impact of
MDA [81]. This evidence generation, synthesis and
policy implication cycle needs further development in
Uganda.
The diversity of malaria transmission in Uganda has
not been used to inform a tailored national strategy.
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centres, home to one in five of Ugandans, and where
further trials of innovative integrated vector manage-
ment in densely populated areas are urgently needed.
One area of malaria intelligence that has to a large ex-
tent been used effectively to inform national policy are
data generated on parasite resistance to first and second-
line anti-malarial medicines [82-85]. However, these senti-
nel data need increased investment to improve six- to
eight-hourly parasite density sampling or molecular sur-
veillance to detect emerging artemesinin resistance [86].
Further intelligence data that has been effectively used to
inform the IRS policy are data on vector resistance to pub-
lic health insecticides [87,88]. However, national patterns
of vector species ecology and the changing vector bio-
nomics in the face of widespread ITN use remains poorly
defined. Vector distribution, their peak biting times and
predominance of indoor versus outdoor biting is critical in
assessing what new paradigms are needed for malaria vec-
tor control in Uganda.
The precise malaria mortality burden in Uganda has
remained unknown since the 1920s, all past and recent
estimates are based on a modelled prediction of sparse
national data: 100,000 annual deaths in 1998 [32,45,46],
modelled data from outside of Uganda applied to Uganda’s
population, 23,126 annual deaths [89] or 17,000 annual
deaths [90] or data reported by the national health in-
formation systems, 10,500 annual deaths [63]. Improv-
ing the use of routine statistics is paramount; however,
interpreting incomplete data of ‘malaria’ among semi-
immune populations continues to be a challenge
[91,92]. Infection prevalence is a less ambiguous metric
[13] and there is a renaissance in rapid, school-based
sampling of malaria infection to monitor change at
sub-national levels [93,94].
There is a tendency among donors and national mal-
aria control programmes to make clear demarcations be-
tween research and M&E, leading to limited funding for
some of the critical areas needed for robust intelligence.
Ideally these two areas should be intimately connected.
Basic requirements for national malaria control planning
are: a) the epidemiological basis of parasite-vector-host
transmission, and b) what interventions work across the
diverse national malaria ecology. Neither has been prop-
erly defined during the rapid expansion of funding for
malaria control in Uganda during the RBM era. Both
were extensively conducted during the GMEP era at a
time when there was limited funding to implement tai-
lored and tested control. As funding becomes harder to
access post-2015, a more rational basis for malaria fund-
ing is required. More data rather than less will be neces-
sary to improve value for money. The Global Fund’s
allocation for M&E under the round-based system was
ring fenced at approximately 10% of the entire grant.The Global Fund’s NFM is commendable because it at-
tempts to align funding windows with national plan-
ning cycles and furnishes upfront indicative funding
that is available to a given country for the three dis-
eases (HIV/AIDS, tuberculosis and malaria). However,
the NFM has removed the ring fencing that previously
protected funding for M&E. Whether this removal of
ring fencing will reduce the prioritization of M&E is
yet to be seen. However, all stakeholders should ensure
that the funding for surveillance, M&E should increase
rather than decrease. Over the next five to ten years,
accountability, impact analysis, financial business cases
supported by a culture of data use should become the
new paradigm by which malaria programmes, govern-
ments and their development partners operate.
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